Sovicille, Italy

Chiara Caramelli

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chiara Caramelli: Innovator in Alzheimer's Treatment

Introduction

Chiara Caramelli is a prominent inventor based in Sovicille, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for Alzheimer's disease. With a total of 2 patents, her work is paving the way for innovative medical solutions.

Latest Patents

Chiara's latest patents focus on S1P3 antagonists. The present invention relates to antagonists of the S1P3 receptor formula (A) as herein described and pharmaceutical compositions thereof. The compounds of formula (A) are useful in the preparation of a medicament, specifically for the treatment of Alzheimer's disease. This groundbreaking research holds promise for improving the lives of those affected by this debilitating condition.

Career Highlights

Chiara Caramelli is associated with Teva Pharmaceutical Industries Limited, where she continues to advance her research and development efforts. Her dedication to innovation in the pharmaceutical industry has established her as a key figure in the quest for effective Alzheimer's treatments.

Collaborations

Chiara has collaborated with notable colleagues, including Cesare Federico and Emanuele Gabellieri. These partnerships enhance the collaborative spirit of innovation within the pharmaceutical field.

Conclusion

Chiara Caramelli's contributions to the development of Alzheimer's treatments through her patents and collaborations highlight her role as a leading inventor in the pharmaceutical industry. Her work is essential in the ongoing fight against Alzheimer's disease, and it reflects the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…